Radio-resistance of PTEN-deficient prostate tumours is enhanced by treatment-induced chemokine signalling and is associated with biochemical recurrence and development of metastasis.

Chris Armstrong, Jonathan Coulter, Chee Wee Ong, Pamela Maxwell, Karl Butterworth, Lyubomska Oksana, Silvia Berlingeri, Melissa LaBonte Wilson, Steven Walker, Joseph O'Sullivan, Manuel Salto-Tellez, Suneil Jain, Ian Mills, T Illidge, Richard Kennedy, Kevin Prise, David Waugh

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 01 Aug 2018
EventAACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research - Disney's Boardwalk Inn, Orlando, United States
Duration: 02 Dec 201705 Dec 2017
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg

Conference

ConferenceAACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research
CountryUnited States
CityOrlando
Period02/12/201705/12/2017
Internet address

Cite this

Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., Butterworth, K., Oksana, L., Berlingeri, S., LaBonte Wilson, M., Walker, S., O'Sullivan, J., Salto-Tellez, M., Jain, S., Mills, I., Illidge, T., Kennedy, R., Prise, K., & Waugh, D. (2018). Radio-resistance of PTEN-deficient prostate tumours is enhanced by treatment-induced chemokine signalling and is associated with biochemical recurrence and development of metastasis.. Poster session presented at AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States.